Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC “Made in U.S.A.”

This article was originally published in The Tan Sheet

Executive Summary

Commission approves five final consent orders Feb. 22 requiring private label OTC analgesic manufacturers who use imported active ingredients to disclose such details when an origin statement is included on product labeling (1"The Tan Sheet" Nov. 12, 2001, p. 3). FTC clears consent orders with Perrigo, Leiner, Pharmaceutical Formulations, Inc., LNK International, A&S Pharmaceutical in separate 5-0 votes...

You may also be interested in...



Generic Analgesic Labeling Foreign Ingredient Reference Required – FTC

Private label OTC analgesic manufacturers who use imported active ingredients will be required to disclose such details when an origin statement is included on product labeling, according to five 1Federal Trade Commission proposed settlements announced Nov. 6

Bluebird Expects Three Filings In 2020, But US Zynteglo Submission Pushed Back

A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.

Balancing Act: China Approves Antiviral For Coronavirus While Promoting Traditional Medicines

Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.

Topics

UsernamePublicRestriction

Register

PS093690

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel